TY - JOUR
T1 - Mechanistic insights into Fe3O4-modified biochar relieving inhibition from erythromycin on anaerobic digestion
AU - Zhang, Zengshuai
AU - Li, Chunxing
AU - Wang, Guan
AU - Yang, Xiaoyong
AU - Zhang, Yanxiang
AU - Wang, Ruming
AU - Angelidaki, Irini
AU - Miao, Hengfeng
PY - 2023
Y1 - 2023
N2 - Anaerobic digestion
(AD) of antibiotic manufacturing wastewater to degrade residual
antibiotics and produce mixture of combustible gases has been
investigated actively in the past decades. However, detrimental effect of residual antibiotic to microbial activities
is commonly faced in AD process, leading to the reduction of treatment
efficiency and energy recovery. Herein, the present study systematically
evaluated the detoxification effect and mechanism of Fe3O4-modified biochar in AD of erythromycin manufacturing wastewater. Results showed that Fe3O4-modified
biochar had stimulatory effect on AD at 0.5 g/L erythromycin existence.
A maximum methane yield of 327.7 ± 8.0 mL/g COD was achieved at 3.0 g/L
Fe3O4-modified biochar, leading to the increase
of 55.7% compared to control group. Mechanistic investigation
demonstrated that different levels of Fe3O4-modified
biochar could improve methane yield via different metabolic pathways
involved in specific bacteria and archaea. Low levels of Fe3O4-modified biochar (i.e., 0.5–1.0 g/L) led to the enrichment of Methanothermobacter sp., strengthening the hydrogenotrophic pathway. On the contrary, high levels of Fe3O4-modified biochar (2.0–3.0 g/L) favored the proliferation of acetogens (e.g., Lentimicrobium sp.) and methanogen (Methanosarcina
sp.) and their syntrophic relations played vital role on the simulated
AD performance at erythromycin stress. Additionally, the addition of Fe3O4-modified
biochar significantly decreased the abundance of representative
antibiotic resistant genes (ARGs), benefiting the reduction of
environmental risk. The results of this study verified that the
application of Fe3O4-modified biochar could
be an efficient approach to detoxify erythromycin on AD system, which
brings high impacts and positive implications for biological antibiotic wastewater treatment.
AB - Anaerobic digestion
(AD) of antibiotic manufacturing wastewater to degrade residual
antibiotics and produce mixture of combustible gases has been
investigated actively in the past decades. However, detrimental effect of residual antibiotic to microbial activities
is commonly faced in AD process, leading to the reduction of treatment
efficiency and energy recovery. Herein, the present study systematically
evaluated the detoxification effect and mechanism of Fe3O4-modified biochar in AD of erythromycin manufacturing wastewater. Results showed that Fe3O4-modified
biochar had stimulatory effect on AD at 0.5 g/L erythromycin existence.
A maximum methane yield of 327.7 ± 8.0 mL/g COD was achieved at 3.0 g/L
Fe3O4-modified biochar, leading to the increase
of 55.7% compared to control group. Mechanistic investigation
demonstrated that different levels of Fe3O4-modified
biochar could improve methane yield via different metabolic pathways
involved in specific bacteria and archaea. Low levels of Fe3O4-modified biochar (i.e., 0.5–1.0 g/L) led to the enrichment of Methanothermobacter sp., strengthening the hydrogenotrophic pathway. On the contrary, high levels of Fe3O4-modified biochar (2.0–3.0 g/L) favored the proliferation of acetogens (e.g., Lentimicrobium sp.) and methanogen (Methanosarcina
sp.) and their syntrophic relations played vital role on the simulated
AD performance at erythromycin stress. Additionally, the addition of Fe3O4-modified
biochar significantly decreased the abundance of representative
antibiotic resistant genes (ARGs), benefiting the reduction of
environmental risk. The results of this study verified that the
application of Fe3O4-modified biochar could
be an efficient approach to detoxify erythromycin on AD system, which
brings high impacts and positive implications for biological antibiotic wastewater treatment.
KW - Anaerobic digestion
KW - Antibiotic resistant genes
KW - Erythromycin manufacturing wastewater
KW - Fe3O4-modified biochar
KW - Metabolic pathway
KW - Microbial community
U2 - 10.1016/j.jenvman.2023.118459
DO - 10.1016/j.jenvman.2023.118459
M3 - Journal article
C2 - 37399623
SN - 0301-4797
VL - 344
JO - Journal of Environmental Management
JF - Journal of Environmental Management
M1 - 118459
ER -